Physician-Dispensed Skincare generally refers to products that trigger biological actions on the skin below the stratum corneum. A “Cosmetic,” by definition, is a product that does not alter the skin’s structure or function. Many physicians whose practices or specialties involve skin health, choose to dispense these cosmeceuticals, or have them specially compounded, to offer heightened results to their patients and to enhance their results with other treatments, such as surgery.
Based on the Physician Dispensed Cosmeceuticals market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Physician Dispensed Cosmeceuticals market covered in Chapter 5:
Jan Marini Skin Research, Inc
Allergan plc
Johnson & Johnson
Procter & Gamble Co.
Solta Medical, Inc
Unilever plc,
L'Oreal S.A.
Jan Marini Skin Research, Inc.
Valeant Pharmaceuticals Inc.
Obagi Medical Products, Inc
ZO Skin Health Inc.
In Chapter 6, on the basis of types, the Physician Dispensed Cosmeceuticals market from 2015 to 2025 is primarily split into:
Skincare Products
Hair care Products
Eye care Products
Injectable Botox
Others
In Chapter 7, on the basis of applications, the Physician Dispensed Cosmeceuticals market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Sales
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Physician Dispensed Cosmeceuticals. Industry analysis & Market Report on Physician Dispensed Cosmeceuticals is a syndicated market report, published as Global Physician Dispensed Cosmeceuticals Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Physician Dispensed Cosmeceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.